Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis.
Amyotrophic lateral sclerosis (ALS is a neurodegenerative disorder which is characterized by motor neuron (MN dysfunction, progressive paralysis, and death. Although several therapeutic approaches have been used for treatment of ALS, little success has been achieved. Natural vectors such as mesenchymal stem cells (MSCs can be a promising tool for overcoming therapeutic problems. MSCs have multipotential characteristics such as the ability to differentiate into variety of cell types, easy access, immunomodulation, tissue repair, exertion of trophic factors, exosome secretion and efficient homing. In this review, we will discuss the characteristics of MSCs and their possible therapeutic mechanisms in ALS patients.
Mahsa
M
Hajivalili
Fatemeh
F
Pourgholi
Hossein Samadi
HS
Kafil
Farhad
F
Jadidi-Niaragh
Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Yousefime@tbzmed.ac.ir.
Mehdi
M
Yousefi
D000690:Amyotrophic Lateral Sclerosis / Q000628:therapy*; D000818:Animals; D006801:Humans; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods*